Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VRP-007
- Development stage
- Preclinical
- Lead developer
- Venus Remedies
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
VRP-007 is a preclinical-stage targeted drug delivery candidate being developed by Venus Remedies (specifically through its research arm, Venus Medicine Research Centre) for the treatment of cancer (oncology). The candidate is designed using Venus's proprietary target-based drug delivery technologies, which include Stealth Targeted Nanodelivery (STN) and Drug-Protein-Polymer-Conjugate (DPPC) platforms. These platforms aim to enhance the influx and retention of active anticancer agents in target cancer cells while minimizing uptake by normal cells, thereby improving therapeutic efficacy and reducing side effects. As of the latest pipeline updates, VRP-007 has completed the formulation and development (F&D) stage, with further preclinical and clinical development pending.
Beyond the preview
Go deeper on VRP-007.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VRP-007.